November 14 2023
Collaboration aimed at optimizing a same-day identification diagnostic system for clinical use.
October 24 2023
"Jeff has been an important advisor, investor and supporter of DZD... the company has benefitted greatly from his involvement and counsel."
October 10 2023
Day Zero Lab Services launches new rapid high resolution organism ID service, epiXact® ID
October 4 2023
We are honored to have Dr. Simner join Day Zero Diagnostics’ Clinical Advisory Board
September 20 2023
This latest financing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding.
August 29 2023
This award funds DZD's development of epiXact®FMT, a pharmacovigilance assay to enhance safety and efficacy in fecal microbiota transplant (FMT) clinical trials.